Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Capital Expenditures (2016 - 2025)

Plus Therapeutics has reported Capital Expenditures over the past 16 years, most recently at $30000.0 for Q4 2025.

  • Quarterly Capital Expenditures rose 172.73% to $30000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $67000.0 through Dec 2025, down 54.11% year-over-year, with the annual reading at $67000.0 for FY2025, 54.11% down from the prior year.
  • Capital Expenditures was $30000.0 for Q4 2025 at Plus Therapeutics, up from $27000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $210000.0 in Q1 2022 and troughed at $3000.0 in Q1 2025.
  • The 5-year median for Capital Expenditures is $33000.0 (2022), against an average of $56823.5.
  • Year-over-year, Capital Expenditures surged 663.64% in 2021 and then crashed 92.5% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $84000.0 in 2021, then soared by 52.38% to $128000.0 in 2022, then crashed by 67.19% to $42000.0 in 2023, then plummeted by 73.81% to $11000.0 in 2024, then skyrocketed by 172.73% to $30000.0 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Capital Expenditures are $30000.0 (Q4 2025), $27000.0 (Q3 2025), and $7000.0 (Q2 2025).